- Report
- September 2025
- 50 Pages
Global
From €2329EUR$2,650USD£2,015GBP
- Report
- August 2025
- 189 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- September 2025
- 564 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- May 2025
- 150 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- August 2025
- 183 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 196 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 182 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 191 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 183 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 194 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 186 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 186 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- May 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- May 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- May 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- April 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- April 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- September 2025
- 250 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- September 2025
- 250 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- September 2025
- 250 Pages
Global
From €3947EUR$4,490USD£3,414GBP

Methotrexate is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriasis, and Crohn's disease. It works by blocking the action of an enzyme involved in the production of certain proteins that are necessary for the growth and development of cells. It is also used to treat certain types of cancer. Methotrexate is available in both oral and injectable forms.
Methotrexate is a widely used drug in the treatment of immune disorders. It is generally well tolerated and has been shown to be effective in reducing symptoms and improving quality of life. It is also used in combination with other drugs to treat more severe cases of immune disorders.
The market for Methotrexate is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and AbbVie. Show Less Read more